Covered recipient · General Payments record
MEGHAN PAGE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2022–2024
$531.58
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $356.78 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $128.83 | 6 |
| TAIHO ONCOLOGY, INC. | $84.06 | 5 |
| Janssen Biotech, Inc. | $30.56 | 1 |
| ARRAY BIOPHARMA INC | $27.54 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.79 | 1 |
| TerSera Therapeutics LLC | $22.81 | 1 |
| PFIZER INC. | $19.13 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $17.06 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.55 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107689710 | CMS |
| ABBVIE INC. | $19.30 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107689712 | CMS |
| ABBVIE INC. | $19.15 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107689714 | CMS |
| ABBVIE INC. | $21.87 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107689716 | CMS |
| ABBVIE INC. | $27.68 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107689718 | CMS |
| ABBVIE INC. | $18.28 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107689720 | CMS |
| ARRAY BIOPHARMA INC | $27.54 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131372315 | CMS |
| Janssen Biotech, Inc. | $30.56 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078372890 | CMS |
| Novartis Pharmaceuticals Corporation | $17.06 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087107994 | CMS |
| PFIZER INC. | $19.13 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131370719 | CMS |
| TAIHO ONCOLOGY, INC. | $16.91 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137938914 | CMS |
| TAIHO ONCOLOGY, INC. | $20.53 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137942522 | CMS |
| TAIHO ONCOLOGY, INC. | $19.17 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137944772 | CMS |
| TAIHO ONCOLOGY, INC. | $13.95 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137935073 | CMS |
| TAIHO ONCOLOGY, INC. | $13.50 | 12/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137944035 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.79 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144980642 | CMS |
| TerSera Therapeutics LLC | $22.81 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144722901 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.